BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3727214)

  • 1. Blood flow in the Dunning R3327H rat prostatic adenocarcinoma; effects of oestradiol and testosterone.
    Daehlin L; Damber JE
    Urol Res; 1986; 14(2):113-7. PubMed ID: 3727214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct effects of oestradiol on growth and morphology of the Dunning R3327H prostatic carcinoma.
    Daehlin L; Bergh A; Damber JE
    Urol Res; 1987; 15(3):169-72. PubMed ID: 3629752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
    Daehlin L
    Scand J Urol Nephrol Suppl; 1985; 91():1-44. PubMed ID: 3868029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 6-methylene progesterone on growth, morphology, and blood flow of the Dunning R3327 prostatic adenocarcinoma.
    Damber JE; Bergh A; Daehlin L; Petrow V; Landström M
    Prostate; 1992; 20(3):187-97. PubMed ID: 1574466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma.
    Landström M; Tomić R; Damber JE
    Eur Urol; 1987; 13(3):203-6. PubMed ID: 2956111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. After radiotherapy testosterone stimulation is unable to increase growth in the dunning R3327-PAP prostate tumour.
    Granfors T; Tomic R; Bergh A; Rydh M; Löfroth PO; Widmark A
    Urol Res; 1999 Oct; 27(5):357-61. PubMed ID: 10550524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal testosterone concentration for the treatment of prostatic cancer.
    Trachtenberg J
    J Urol; 1985 May; 133(5):888-90. PubMed ID: 3989932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone-induced decrement of prostatic vascular resistance in rats is reversed by estrogens.
    Daehlin L; Damber JE; Selstam G; Bergman B
    Prostate; 1985; 6(4):351-9. PubMed ID: 4088949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estramustine potentiates the effects of irradiation on the Dunning (R3327) rat prostatic adenocarcinoma.
    Widmark A; Damber JE; Bergh A; Henriksson R
    Prostate; 1994; 24(2):79-83. PubMed ID: 8309847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrement of blood flow precedes the involution of the ventral prostate in the rat after castration.
    Lekås E; Johansson M; Widmark A; Bergh A; Damber JE
    Urol Res; 1997; 25(5):309-14. PubMed ID: 9373910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
    Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of rat prostatic adenocarcinoma with medroxyprogesterone acetate (MPA): effects on growth and morphology.
    Damber JE; Bergh A; Landström M; Tomić R
    J Urol; 1991 Jun; 145(6):1283-7. PubMed ID: 1827847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
    Sylvester PW; Ip MM
    Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of microcapsules of luteinizing hormone-releasing hormone antagonist SB-75 and somatostatin analog RC-160 on endocrine status and tumor growth in the Dunning R-3327H rat prostate cancer model.
    Yano T; Pinski J; Szepeshazi K; Milovanovic SR; Groot K; Schally AV
    Prostate; 1992; 20(4):297-310. PubMed ID: 1351672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between local circulatory changes in the tibia and kidney of male and female rats after castration and administration of estradiol or testosterone.
    Kapitola J; Andrle J; Kubícková J
    Endocr Regul; 1994 Mar; 28(1):41-6. PubMed ID: 7949013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system-mediated growth inhibition of a rat prostate carcinoma by an opioid.
    Reubi JC
    J Endocrinol; 1985 Nov; 107(2):247-50. PubMed ID: 4067481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats.
    Rosenberg CA; Hrushesky WJ; Langevin T; Kennedy BJ
    Oncology; 1985; 42(1):48-54. PubMed ID: 3969257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumoral effects of R 75251 on the growth of transplantable R3327 prostatic adenocarcinoma in rats.
    Van Ginckel R; De Coster R; Wouters W; Vanherck W; van der Veer R; Goeminne N; Jagers E; Van Cauteren H; Wouters L; Distelmans W
    Prostate; 1990; 16(4):313-23. PubMed ID: 2371176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Castration plus oestrogen treatment induces but castration alone suppresses epithelial cell apoptosis in an androgen-sensitive rat prostatic adenocarcinoma.
    Westin P; Brändström A; Damber JE; Bergh A
    Br J Cancer; 1995 Jul; 72(1):140-5. PubMed ID: 7599043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of a cloned cell line R3327H-G8-A1 derived from the dunning R3327H rat adenocarcinoma.
    Sestili MA; Norris JS; Smith RG
    Cancer Res; 1983 May; 43(5):2167-75. PubMed ID: 6299542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.